NCT04293133 is a clinical trial in Congenital Adrenal Hyperplasia, sponsored by Ain Shams University.

Who is sponsoring NCT04293133?

NCT04293133 is sponsored by Ain Shams University.

What condition does NCT04293133 study?

NCT04293133 studies Congenital Adrenal Hyperplasia.

Is NCT04293133 still recruiting?

NCT04293133 is currently status unknown. Last updated 3 March 2020.

Last reviewed 2020-03-03 · How we verify

NCT04293133

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Final Height in Patients With CAH

Status unknown Last updated 3 March 2020

What this trial tests

trial in Congenital Adrenal Hyperplasia in 30 participants. Status unknown.

Timeline

11 March 2020

Primary endpoint
11 August 2020

11 September 2020

Quick facts

Lead sponsor	Ain Shams University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	11 March 2020
Primary completion	11 August 2020
Estimated completion	11 September 2020

Conditions studied

Congenital Adrenal Hyperplasia — all drugs for Congenital Adrenal Hyperplasia →

Sponsor

Ain Shams University

Who can join

Under 18, any sex, with Congenital Adrenal Hyperplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Congenital adrenal hyperplasia (CAH) is the most common inherited disorder in the adrenal gland in children. Growth is usually affected in CAH patients either due to the disease itself or treatment consequences.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Adrenal Hyperplasia

Currently open trials in the same condition.

NCT07187375 — Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Le · Phase 2 · recruiting
NCT06573723 — Institutional Registry of Rare Diseases · recruiting
NCT05669950 — A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia · Phase 1, PHASE2 · recruiting
NCT06754423 — Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency · recruiting
NCT04890444 — China Adrenal Disease Registry · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04293133 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 3 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04293133.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing